Figure 3
From: Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia
(a) Changes in serum uric acid with uric acid-lowering drugs: −2.6±1.8 (n=20 in febuxostat (Feb)), −3.2±1.6 (n=20 in Feb/Ben), −2.6±1.8 (n=20 in benzbromarone (Ben)), **P<0.01 vs. Feb, ††P<0.01 vs. Feb/Ben. (b) Changes in urinary uric acid/creatinine with uric acid-lowering drugs: −0.17±0.16 (n=20 in Feb), −0.12±0.23 (n=20 in Feb/Ben), 0.04±0.24 (n=20 in Ben), **P<0.01, *P<0.05 vs. Feb, ††P<0.01 vs. Feb/Ben.
